Clinical Trials Browser

Phase 1/2 × OTHER_GOV × Lymphoid × Clear all

NCT07135466 2026-01-16

A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies

Phase 1/2 Recruiting

50 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT06299462 2025-02-25

PTCy and ATG for MSD and MUD Transplants

Phase 1/2 Recruiting

50 enrolled

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02772198 2020-11-03

T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies

Phase 1/2 Unknown

300 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03263208 2017-10-20

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

Phase 1/2 Unknown

20 enrolled

Lymphoid

Burkitt Lymphoma

NCT02488382 2017-10-17

Lonquek for Autologous Stem Cell Mobilization

Phase 1/2 Unknown

24 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT02145923 2015-06-10

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Phase 1/2 Unknown

16 enrolled

Classical hematologyLymphoid

Anemia, Aplastic, Hodgkin Disease, Enterocolitis, Neutropenic

NCT00432419 2011-12-22

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Phase 1/2 Terminated

1 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, HIV Infections